Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
2.100
-0.040 (-1.87%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $90.76 million as of April 28, 2025. Its market cap has decreased by -91.47% in one year.
Market Cap
90.76M
Enterprise Value
-186.98M
1-Year Change
-91.47%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $90.76M, a decrease of -89.89%. That is a compound annual growth rate of -84.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 90.76M | -43.79% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |